During the past decade, Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research" are "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials) and "Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research" in a lesser frequency.

Most popular intervention types in "Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Endocrine Therapy of Physician's Choice" (1 trials), "Fulvestrant" (1 trials), "Giredestrant" (1 trials), "LHRH Agonist" (1 trials) and "Trastuzumab Emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mater Hospital; Patricia Ritchie Centre for Cancer Care and Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".